By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Novartis AG 

Lichtstrasse 35

Basel    CH-4056  Switzerland
Phone: 41-0-61-3241111 Fax: 41-0-61-3248001


SEARCH JOBS

Novartis is located in East Hanover, New Jersey, Novartis Pharmaceuticals Corporation is an affiliate of Novartis AG, which provides innovative healthcare solutions that address the evolving needs of patients and societies. Headquartered in Basel, Switzerland, Novartis offers a diversified portfolio to best meet these needs: innovative medicines, eye care and cost-saving generic pharmaceuticals. Novartis is the only global company with leading positions in these areas. In 2015, the Group achieved net sales of USD 49.4 billion, while R&D throughout the Group amounted to approximately USD 8.9 billion (USD 8.7 billion excluding impairment and amortization charges). Novartis Group companies employ approximately 118,000 full-time-equivalent associates. Novartis products are available in more than 180 countries around the world.

For more information, visit
www.novartis.com and follow us on www.twitter.com/Novartis

YEAR FOUNDED:

1996

LEADERSHIP:

CEO: Joseph Jimenez

CMO: Vasant (Vas) Narasimhan

CFO: Harry Kirsch

JOBS:

Please click here for Novartis job opportunities.

CLINICAL TRIAL:

Please click here for clinical trial information.

PRODUCTS:

All Products

FOLLOW NOVARTIS:








Key Statistics


Email:
Ownership: Subsidiary

Web Site: Novartis AG
Employees:
Symbol: NVS
 



Industry
Services






Company News
Novartis AG (NVS) Data Shows Half Of Eligible Ph+ CML-CP Patients Remain In Treatment-Free Remission Nearly Two Years After Stopping Tasigna 6/23/2017 10:41:38 AM
Novartis AG (NVS) Pivotal CTL019 6-Month Follow-Up Data Show Durable Remission Rates In Children, Young Adults With R/R B-Cell ALL 6/23/2017 10:38:57 AM
Novartis AG (NVS) Pivotal CTL019 6-Month Follow-Up Data Show Durable Remission Rates In Children, Young Adults With R/R B-Cell ALL 6/23/2017 7:19:31 AM
Ocular Therapeutix (OCUL) Names Bristol-Myers Squibb (BMY)-Novartis AG (NVS) Vet As New CEO 6/23/2017 7:19:04 AM
Novartis AG (NVS) Combination Targeted Therapy Tafinlar + Mekinist Receives FDA Approval For BRAF V600E Mutant Metastatic Non-Small Cell Lung Cancer (NSCLC) 6/23/2017 6:28:12 AM
Regeneron (REGN) Details Royalty Agreement With Novartis AG (NVS) For Canakinumab (ACZ885) 6/22/2017 7:47:17 AM
Surprise: Novartis AG (NVS) Heart Drug Wows in Late-Stage Study 6/22/2017 7:19:56 AM
Novartis AG (NVS) Achieves Important Regulatory Milestone For AMG 334 (Erenumab) In Migraine Prevention With EMA Filing Acceptance 6/21/2017 8:15:21 AM
Novartis AG (NVS) Rejects Trump's Proposition to Create More U.S Jobs 6/21/2017 5:41:00 AM
Novartis AG (NVS) Real World Study Shows Almost Half Of Chronic Urticaria Patients Are Not Receiving Any Treatment Despite Significant Disease Burden 6/20/2017 10:19:10 AM
12345678910...
//-->